Levomecor Inc.
Clinical trials sponsored by Levomecor Inc., explained in plain language.
-
New depression pill shows promise in Late-Stage trial
Symptom relief TerminatedThis study tested whether adding REL-1017 to standard antidepressant therapy could better reduce depression symptoms in adults with major depressive disorder. About 236 participants took either REL-1017 or a placebo pill daily, along with their usual medication. The trial was sto…
Phase: PHASE3 • Sponsor: Levomecor Inc. • Aim: Symptom relief
Last updated May 26, 2026 05:39 UTC
-
New depression pill shows promise in early trial
Symptom relief TerminatedThis study tested a new drug called REL-1017 as an extra treatment for people with major depression who didn't get enough help from standard antidepressants. The trial was stopped early after enrolling 27 adults. Researchers measured changes in depression symptoms using a standar…
Phase: PHASE3 • Sponsor: Levomecor Inc. • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC